Bio Connections Australia explores drug development, early phase clinical trials, translational research and expediting Australia’s great science into commercialization. It comes at a critical time for Australia’s medical research sector.
The focus of the agenda this year will be on translation and commercialization of homegrown Australian research, improving drug development and clinical trials in Australia as well as the impact of COVID-19 on the landscape.
Bio Connections Australia provides an important platform for further discussion and debate on what the challenges, opportunities and realities may be for drug development, clinical trials and medical research in Australia.
Our communities are keen to reconnect, network, and learn more than ever after months of disruption. We are excited to be moving back to face-to-face events but will continue to offer the option to attend the event virtually.
Bio Palooza Dinner is back
We are delighted to announce the event highlight Bio Palooza Dinner will be returning for the 2021 edition of Bio Connections Australia. Don’t miss out on this intimate get together and key networking opportunity to further discuss and connect following the conference with your fellow delegates and speakers in this informal setting.
2020 Sponsors & Eexhibitors
Bio Box Australia
Bio Box Australia is a video-on-demand service providing a deeper dive on key topics, themes and questions relating to Bio Connections Australia. Bio Box will explore a wide range of topic areas including drug discovery and development, clinical trials, translating research, commercialization, going global strategies, capital raising and much more! It offers a range of perspectives from Australia and abroad.
Each Bio Box Australia episode be different with a mix of fireside chats, panels, presentations, bespoke digital theatre recordings and much more! Each month we release a new episode on a different topic.
The best part? This content is available in the lead-up to, during and after the Bio Connections Australia event each year so you can keep coming back!
NEXT UPCOMING BIO BOX:
Episode 6: Understanding & Navigating the US Market
Episode 7: Planning for Phase 1 Clinical Trials in Australia in the COVID-19 Era
Bio Box Speakers
Nicoletta Muner, Managing Director, Canary Regulatory Affairs
Adriana Stefancic, Managing Director & Principal Consultant, Adriaus Consulting
Prof. Dean Ho, Provost’s Chair Professor, Director of The N.1 Institute for Health (N.1), Director of the Institute for Digital Medicine (WisDM), and Head of the Department of Biomedical Engineering at the National University of Singapore
Rosa Gonzalez Galindo, Sr Vice President Clinical Development, Immunology and Inflammation, Syneos Health
Michael Tucker, Senior mHealth Solutions Specialist, Medidata, a Dassault Systèmes company
Dr Tina Soulis, Chief Executive Officer, Neuroscience Trials Australia